Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
19 Cards in this Set
- Front
- Back
Osmotic Diuretic site of action/MOA
|
Proximal tubule, descending loop of henle
Draws water out of cells and into the filtrate (urine) |
|
Carbonic Anhydrase Inhibitor site of action/MOA
|
Proximal tubule
Inhibition of carbonic anhydrase activity |
|
Loop site of action/MOA
|
Thick ascending limb of loop of henle
Na+ K+ 2Cl- symporter function |
|
Thiazide site of action/MOA
|
Distal tubule
Inhibition of Na+ Cl- symport |
|
Potassium sparing site of action/MOA
|
Mineralocorticoid receptor inhibitors
-Late distal, collecting tubule -Effect is a function of aldosterone levels -Decrease Na+ absorption -Decrease K+ excretion Pteridines -Late distal, collecting tubule -Inhibition of Na+ influx channel Aminopyrazines -Late distal, collecting tubule -Inhibition of Na+ influx channel |
|
Vasopressin receptor antagonists site of action/MOA
|
-Collecting duct
-Antagonists of ADH |
|
Osmotic diuretic uses
|
-Dialysis disequilibrium syndrome
-Acute glaucoma attacks (control intraocular pressure) -Cerebral edema pre- and post-neurosurgery |
|
Carbonic anhydrase inhibitor uses
|
-Glaucoma
-Urinary alkalinization -Acute mountain sickness -Treatment of CSF leakage (head trauma) |
|
Loop diuretic uses
|
-Acute pulmonary edema or other edematous states
-Heart failure (treatment of edema) -Acute hypercalcemia -Hyperkalemia -Acute renal failure -Anion overdose |
|
Thiazide uses
|
-Management of HTN
-Heart failure (treatment of edema) -Nephrogenic diabetes insipidus -kidney stones |
|
Potassium sparing diuretic uses
|
Mineralocorticoid receptor inhibitors
-Edema (combo w/ loops or thiazides) -Pt w/ hepatic cirrhosis -HTN in pts w/ hypoaldosteronism Pteridines -Antihypertensive (combo w/ loops or thiazides) Aminopyrazines -Antihypertensive (combo w/ loops or thiazides) |
|
Vasopressin receptor antagonist effects
|
-Increase urine output
-Increase water reabsorption -No change in systemic vascular resistance |
|
Osmotic diuretic toxicity
|
-Dehydration, hyponatremia
-Hypernatremia -Hyperkalemia -Complicate heart failure |
|
Carbonic anhydrase inhibitor toxicity
|
-Hyperchloremic metabolic acidosis
-Phosphaturia and hypercalciuria -Renal stones -hypersensitivity rxns -K+ wasting |
|
Loop diuretic toxicity
|
-Hypokalemic metabolic alkalosis
-Ototoxicity -Hyperuricemia -Hypomagnesemia -Skin rashes -Dehydration and hyponatremia |
|
Thiazide toxicity
|
-Hypokalemia metabolic alkalosis
-Hyperlipidemia -Hyponatremia -Decrease glucose tolerance -Skin rashes and photosensitivity |
|
Potassium sparing diuretic toxicity
|
Mineralocorticoid receptor inhibitors
-Hyperkalemia -Gynecomastia -Acute renal failure -Kidney stones -Peptic ulcers -Skin rashes -Nausea/vomiting Pteridines -Hyperkalemia -Acute renal failure [triamterene+indomethacin] -Kidney stones Aminopyrazines -Hyperkalemia |
|
Vasopressin receptor antagonist side effects
|
V1aR and V2R antagonist
-Hypotension -Nephrogenic diabetes insipidus -Hypokalemia Inhibitor of V2 receptors -Nausea/vomiting -Visual disturbances |
|
Which diuretic is a CYP3A4 inhibitor?
|
Spironolactone
|